The company
DexCom, Inc.
DXCM · Nasdaq
Health CareMedical DevicesLeading
DXCM stood above a rising 150-day average in 19 of the last 52 weekly readings, including each of the last 16 weeks. It is 13.8% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 16 in a row
- Industry in uptrend
- 29% -5 in 4 wk
- Insider buys, 12 months
- $1.0M
- Insider sales, 12 months
- $24.9M
- Officials’ trades on record
- 44
- Institutions holding
- 901 (+8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
21 Apr – 20 Oct
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars.
Congress and officials
44 disclosed lines: House 27, Senate 4, executive 13; 14 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 17 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 18 May 2026filed 1 Jul 2026 |
| Tina Smith Senate: U.S. Senate eFDSenator | soldspouse | $100k–$250k | 7 May 2026filed 10 May 2026 |
| Tina Smith Senate: U.S. Senate eFDSenator | sold part ofspouse | $100k–$250k | 29 Apr 2026filed 10 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 27 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 27 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 17 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 10 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 7 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 17 Mar 2026filed 14 May 2026 |
Insiders
Buy orders, 12 months1
Sale orders, 12 months28
Buyers · sellers1 · 9
| Who | Did | Shares | Traded |
|---|---|---|---|
| Michael Jon BrownEVP Chief Legal Compliance Off | sold | 1,700at $85.48 | 15 Oct 2026filed 19 Oct 2026 |
| Sadie SternEVP Chief People & Culture Off | sold | 2,565at $86.15 | 28 Sep 2026filed 30 Sep 2026 |
| Michael Jon BrownEVP Chief Legal Compliance Off | sold | 1,700at $84.04 | 15 Sep 2026filed 16 Sep 2026 |
| Nicholas AugustinosDirector | sold | 6,539at $84.04 | 15 Sep 2026filed 16 Sep 2026 |
| Nicholas AugustinosDirector | sold | 1,550at $84.02 | 14 Sep 2026filed 16 Sep 2026 |
| Jereme M. SylvainEVP, Chief Financal Officer | sold | 3,638at $83.27 | 10 Sep 2026filed 14 Sep 2026 |
| Sadie SternEVP Chief People & Culture Off | sold | 2,565at $88.37 | 27 Aug 2026filed 28 Aug 2026 |
| Kevin R. SayerExecutive Chair | sold | 19,308at $89.71 | 20 Aug 2026filed 24 Aug 2026 |
| Kevin R. SayerExecutive Chair | sold | 7,351at $90.78 | 20 Aug 2026filed 24 Aug 2026 |
| Kevin R. SayerExecutive Chair | sold | 97at $91.41 | 20 Aug 2026filed 24 Aug 2026 |
| Michael Jon BrownEVP Chief Legal Compliance Off | sold | 1,700at $91.93 | 14 Aug 2026filed 17 Aug 2026 |
| Bridgette P. HellerDirector | sold | 1,012at $88.29 | 12 Aug 2026filed 13 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Holders901+8 on the quarter
New · exited119 · 114
Reported value$25.3B
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 38,244,137$2.6B | -720,234−1.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 25,209,752$1.7B | +188,791+0.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 19,656,540$1.3B | +436,587+2.3% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 18,380,806$1.2B | +445,959+2.5% |
| Invesco Ltd.added · filed 14 Aug 2026 | 15,288,133$1.0B | +9,693,273+173.3% |
| BAILLIE GIFFORD & COreduced · filed 6 Aug 2026 | 14,801,590$996.9M | -797,935−5.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 12,426,515$834.2M | +79,877+0.6% |
| ALLIANCEBERNSTEIN L.P.reduced · filed 14 Aug 2026 | 11,693,409$734.3M | -1,230,235−9.5% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCadded · filed 13 Aug 2026 | 11,261,876$758.5M | +1,515,702+15.6% |
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 8,527,471$574.3M | -798,769−8.6% |
31 Mar 2023 – 30 Jun 2026
News
DexCom Aktie: Kurs, Chart, Kursziel & Newsboerse-express.com · 6 Oct 2026Dexcom Finds CGM Awareness And Access Challenges In Type 2 Diabetesrttnews.com · 28 Sep 2026Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Caretimesargus.com · 28 Sep 2026Dexcom's CFO Jereme Sylvain To Take Addl. Role Of COOrttnews.com · 15 Sep 2026DexCom Stock: Is DXCM Underperforming the Healthcare Sector?yahoo.com · 9 Sep 2026
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.